Blackwell teams up with Cygenex to strengthen preventive health

Blackwell Captive Solutions has announced a new strategic partnership with advanced diagnostic testing and personalised preventive health solution company Cygenex. Through this collaboration, Cygenex will become part of B.Well Edge, Blackwell’s portfolio of best-in-class solutions designed to help employers proactively manage healthcare costs and improve outcomes.

“B.Well Edge is about giving employers access to innovative programs that drive measurable results,” said Scott Byrne, president of Blackwell Captive Solutions. “Cygenex’s expertise in understanding healthcare and genetic risks adds an important layer of precision and preventive insight—helping employers address risks earlier and improve member health while lowering long-term costs.”

Cygenex brings a portfolio of advanced diagnostic testing and an early detection risk platform that empowers clinicians, employers, and employees to identify health risks before they escalate into costly claims. This proactive and preventative approach aligns directly with Blackwell’s mission of bending the healthcare cost curve for self-funded employers.

“At Cygenex, our mission is to provide employers and individuals with actionable health insights that can change lives,” said Charles Clark, chief executive and chief technical officer of Cygenex, “Partnering with Blackwell allows us to deliver our solutions within a forward-thinking captive model that prioritises innovation, risk management, and better outcomes for employees.”

As part of B.Well Edge, Cygenex is available to all Blackwell members as an optional buy-up solution, complementing the B.Well Blueprint core offerings that are included for every Blackwell group.

Did you get value from this story?  Sign up to our free daily newsletters and get stories like this sent straight to your inbox.